Compare RFIL & TELA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RFIL | TELA |
|---|---|---|
| Founded | 1979 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electrical Products | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 61.6M | 50.8M |
| IPO Year | N/A | 2019 |
| Metric | RFIL | TELA |
|---|---|---|
| Price | $5.78 | $1.12 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 4 |
| Target Price | ★ $9.25 | $3.31 |
| AVG Volume (30 Days) | 55.3K | ★ 100.1K |
| Earning Date | 01-14-2026 | 11-13-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $76,353,000.00 | ★ $77,055,000.00 |
| Revenue This Year | $21.53 | $18.41 |
| Revenue Next Year | $4.92 | $15.20 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 22.60 | 12.24 |
| 52 Week Low | $3.39 | $0.86 |
| 52 Week High | $9.56 | $3.08 |
| Indicator | RFIL | TELA |
|---|---|---|
| Relative Strength Index (RSI) | 41.77 | 45.02 |
| Support Level | $5.54 | $1.08 |
| Resistance Level | $6.33 | $1.16 |
| Average True Range (ATR) | 0.31 | 0.06 |
| MACD | 0.03 | 0.00 |
| Stochastic Oscillator | 23.07 | 34.62 |
RF Industries Ltd is engaged in the design, manufacture, and marketing of interconnect products and systems, including coaxial and specialty cables, fiber optic cables and connectors, and electrical and electronic specialty cables. The company operates through two segments: RF Connector and Cable Assembly, which consists of the Connector and Cable Assembly Division, and Custom Cabling Manufacturing and Assembly, which consists of its subsidiaries. Connector segment designs, manufactures, markets and distributes a broad range of RF connector, adapter, coupler, divider, and cable products etc. The Custom Cabling segment custom copper and fiber cable assemblies etc. The company operates in Canada, Italy, China, USA, UK.
TELA Bio Inc a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. Its growing product portfolio is purposefully designed to leverage the patient's natural healing response while minimizing long-term exposure to permanent synthetic materials. The company's OviTex portfolio consists of multiple product configurations intended to address various surgical procedures within hernia repair and abdominal wall reconstruction, including ventral, inguinal, and hiatal hernia repair.